Search

Iesato, Asumi, Stephanie Li, Giovanni Roti, Michele R Hacker, Andrew H Fischer, and Carmelo Nucera. 2021. “Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.”. The Journal of Clinical Endocrinology and Metabolism 106 (12): 3569-90.

McGonagle, Elizabeth R, and Carmelo Nucera. 2019. “Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision Therapy.”. Frontiers in Endocrinology 10: 468.

Nucera, Carmelo, Jack Lawler, Richard Hodin, and Sareh Parangi. 2010. “The BRAFV600E Mutation: What Is It Really Orchestrating in Thyroid Cancer?”. Oncotarget 1 (8): 751-56.

Nucera, Carmelo, Jerome Eeckhoute, Stephen Finn, Jason S Carroll, Azra H Ligon, Carmen Priolo, Guido Fadda, et al. 2009. “FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15 (11): 3680-9.

Moleti, Mariacarla, Filiberto Mattina, Ignazio Salamone, Maria Antonia Violi, Carmelo Nucera, Sergio Baldari, Maria Grazia Lo Schiavo, Concetto Regalbuto, Francesco Trimarchi, and Francesco Vermiglio. 2003. “Effects of Thyroidectomy Alone or Followed by Radioiodine Ablation of Thyroid Remnants on the Outcome of Graves’ Ophthalmopathy.”. Thyroid : Official Journal of the American Thyroid Association 13 (7): 653-8.

Iesato, Asumi, Stephanie Li, Peter M Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler, and Carmelo Nucera. 2023. “The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.”. Thyroid : Official Journal of the American Thyroid Association 33 (7): 835-48.

Valvo, Veronica, and Carmelo Nucera. 2019. “Coding Molecular Determinants of Thyroid Cancer Development and Progression.”. Endocrinology and Metabolism Clinics of North America 48 (1): 37-59.

Smith, Neal, and Carmelo Nucera. 2015. “Personalized Therapy in Patients With Anaplastic Thyroid Cancer: Targeting Genetic and Epigenetic Alterations.”. The Journal of Clinical Endocrinology and Metabolism 100 (1): 35-42.

Nucera, Carmelo. 2013. “Targeting Thyroid Cancer Microenvironment: Basic Research and Clinical Applications.”. Frontiers in Endocrinology 4: 167.

Shaik, Shavali, Carmelo Nucera, Hiroyuki Inuzuka, Daming Gao, Maija Garnaas, Gregory Frechette, Lauren Harris, et al. 2012. “SCF(β-TRCP) Suppresses Angiogenesis and Thyroid Cancer Cell Migration by Promoting Ubiquitination and Destruction of VEGF Receptor 2.”. The Journal of Experimental Medicine 209 (7): 1289-307.